MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
February 22, 2021

Cemiplimab Improves Survival for PD-L1-Positive NSCLC

By Adam Hochron

A recent phase 3 clinical trial studied the use of cemiplimab as a first-line treatment of advanced non-small-cell lung cancer with a PDL1 of at least 50%...
Cemiplimab Improves Survival for PD-L1-Positive NSCLC
February 16, 2021

Novel Oral Therapy Effective for Patients With Heavily Pretreated Chronic GVHD

By Cameron Kelsall, /alert Contributor

Belumosudil exhibited strong efficacy and a tolerable safety profile as a treatment for patients with heavily pretreated chronic graft-versus-host disease (GVHD)...

Novel Oral Therapy Effective for Patients With Heavily Pretreated Chronic GVHD
February 12, 2021

META-ANALYSIS: Second IL-17 Inhibitor Effective After Failing Initial Psoriasis Treatment

By Adam Hochron

For patients diagnosed with psoriasis, the course of the disease can result in having to change medications multiple times. A recent systematic review and meta-analysis looked at whether the use of a second interleukin 17 (IL-17) inhibitor is safe and effective...
META-ANALYSIS: Second IL-17 Inhibitor Effective After Failing Initial Psoriasis Treatment
February 8, 2021

New Screening Algorithms Aim to Help Improve Breast Cancer Diagnosis

By Adam Hochron

New algorithms designed to improve the diagnosis of certain forms of breast cancer have been launched and are currently available to patients and providers...

New Screening Algorithms Aim to Help Improve Breast Cancer Diagnosis
February 5, 2021

FDA Approves Tepotinib for Metastatic NSCLC with MET exon 14 Alterations

By Adam Hochron

The FDA has granted accelerated approval to tepotinib for adults with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations...

FDA Approves Tepotinib for Metastatic NSCLC with MET exon 14 Alterations
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Dapagliflozin could rapidly curb worsening heart failure, death

By Marilynn Larkin NEW YORK (Reuters Health) - In heart failure patients with reduced ejection fraction, dapagliflozin was associated with a rapid reduction in the risk of cardiovascular death or Read More »

Photoselective vaporization safely alleviates refractory LUTS in prostate cancer patients

By Matthew Phelan NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic Read More »

Continuous glucose monitoring curbs hyperglycemia, hypoglycemia in preemies

By Marilynn Larkin NEW YORK (Reuters Health) - In preterm infants, continuous glucose monitoring (CGM) reduced prolonged or severe hyperglycemia and hypoglycemia in an international randomized Read More »

Pregnant women infected by COVID-19 at higher rate

By Reuters Staff (Reuters) - Pregnant women become infected with the new coronavirus at higher rates than other adults, according to new data from Washington state. Between March and June there, for Read More »

Thrombectomy an option for primary distal posterior cerebral artery occlusion stroke

By Reuters Staff NEW YORK (Reuters Health) - Mechanical thrombectomy is a "reasonable, safe and technically feasible" option for isolated posterior circulation distal, medium vessel occlusion (DMVO) Read More »

Empathetic phone calls from laypersons reduce loneliness, depression in homebound adults

By Linda Carroll (Reuters Health) - A layperson-delivered empathy-oriented phone call program may reduce loneliness as well as depression and anxiety in homebound adults, a new study suggests. Based Read More »

High-dose baclofen curbs agitation in ventilation patients with unhealthy alcohol use

By Lisa Rapaport (Reuters Health) - Adults receiving mechanical ventilation who meet the criteria for unhealthy alcohol use have fewer agitation-related events when they're given high-dose baclofen, a Read More »

UPDATE 1-COVID-19 vaccine makers tell Congress U.S. supply will surge soon

(Adds new details from hearing, CVS, background) By Michael Erman and Manojna Maddipatla NEW YORK (Reuters) - COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information